Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-13

FDA Approved: FOSPHENYTOIN SODIUM — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved an original generic application for fosphenytoin sodium, enabling a generic version of this anticonvulsant to be marketed by Sagent Pharmaceuticals…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosphenytoin Sodium (fosphenytoin sodium)

Snippet

ORIG AP for FOSPHENYTOIN SODIUM (FOSPHENYTOIN SODIUM)